Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 875 across all filing types
Latest filing 2018-07-20 Interim / Quarterly Rep…
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial report ('Kvartalsrapport') for the period 1 April–30 June 2018. It contains detailed financial statements, management commentary, operational highlights, and analysis of business trends. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it fits the definition of an Interim/Quarterly Report. Q2 2018
2018-07-20 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report, 1 April–30 June 2018' and contains detailed financial statements, management commentary, and operational highlights for the second quarter. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2018
2018-07-20 English
New Japanese patent approval for Episurf Medical
Regulatory Filings Classification · 95% confidence The document announces a specific, non-financial event: the granting of a new Japanese patent for Episurf Medical. It includes quotes from the CEO, contact information, and a brief 'About' section. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a standard regulatory filing like a Director's Dealing (DIRS) or Major Shareholding (MRQ). It is a specific announcement regarding intellectual property/product development. Since there is no specific category for 'Patent Approval Announcement', and it is a formal announcement required under market regulations (EU Market Abuse Regulation mentioned), the most appropriate general category is 'Regulatory Filings' (RNS), which serves as the fallback for miscellaneous regulatory announcements that don't fit the highly specific categories provided.
2018-07-06 English
Nytt patentbeviljande i Japan för Episurf Medical
Regulatory Filings Classification · 95% confidence The document is a short announcement in Swedish regarding a new patent granted in Japan for Episurf Medical. It details the patent's subject matter (method and node for manufacturing surgical equipment for cartilage injuries) and includes a quote from the CEO. The final paragraph states that the information is required to be made public under the EU's Market Abuse Regulation (MAR) and was released at a specific time on July 6, 2018. This structure—a brief announcement of a specific, non-financial corporate event (patent grant) released under regulatory obligation—does not fit the specific categories like 10-K, ER, or IR. It is not a Director's Dealing (DIRS), a Capital Change (CAP), or a Dividend Notice (DIV). Since it is a specific regulatory disclosure that doesn't fit the other detailed categories (like AGM-R, 10-K, ER, CT, etc.), the most appropriate fallback category is Regulatory Filings (RNS), as it is a general regulatory announcement.
2018-07-06 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for 'Serendipity Group AB' in 'Episurf Medical AB'. It explicitly mentions 'Reason for major shareholding notification' and provides 'Before the transaction' and 'After the transaction' figures for shares and voting rights, culminating in a new percentage (33.45121%). This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the code MRQ.
2018-07-04 English
Förändring av antalet aktier och röster i Episurf Medical
Share Issue/Capital Change Classification · 99% confidence The document details specific changes in the number of shares and votes due to A-share to B-share conversions and the conversion of convertible notes issued under a previous financing agreement. It explicitly mentions the total number of shares and votes after the change. This type of announcement, focusing on changes in the capital structure (share count, conversions, financing instruments affecting equity), aligns best with the 'Share Issue/Capital Change' category (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a dividend notice (DIV). The final sentence confirms it is information the company is obliged to disclose under EU market abuse regulation, suggesting a mandatory regulatory disclosure related to share structure.
2018-06-29 Swedish

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.